Web Results

motion to terminate the IPR

www.pbwt.com/content/uploads/2016/09/IPR2015-01624_Joint_Motion_to_Terminate_082416-1.pdf

Aug 24, 2016 ... Expert Report of John Fiddes, Ph.D., Bristol-Myers Squibb. Company v. ... Goeddel, D.V., et al., Expression in Escherichia coli of chemically ... Declaration of Julie L. Davis, Sanofi-Aventis U.S. LLC v. Genentech, Inc.

Settlement Agreement Bristol-Myers Squibb Co Watson Dnabury ...

www.ag.ny.gov/sites/default/files/pdfs/bureaus/antitrust/buspirone.pdf

"Action" means State ofAlabama, et al v. Bristol-Myers Squibb, et al., MDL No. 1413. (S.D.N.Y.). BB. "Releasers" means Plaintiff States, and the Settling Members ...

Hood, ex rel. Mississippi v. Bristol-Myers Squibb Company, Sanofi ...

www.chamberlitigation.com/hood-ex-rel-mississippi-v-bristol-myers-squibb-company-sanofi-aventis-et-al

Hood, ex rel. Mississippi v. Bristol-Myers Squibb Company, Sanofi-Aventis, et al. ... U.S. Chamber Amicus Brief - Hood ex rel Mississippi v. BMS, Sanofi, et al.

Bristol-Myers Squibb Co. v. Superior Court of California, San ...

www.scotusblog.com/case-files/cases/bristol-myers-squibb-co-v-superior-court-of-california-san-francisco-county/

Nov 10 2016, Brief amici curiae of Washington Legal Foundation, et al. filed. ... Dec 20 2016, Reply of petitioner Bristol-Myers Squibb Company filed.

Bristol-Myers Squibb - A global biopharmaceutical company

www.bms.com/

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail ...

JCI Insight - B cells from African American lupus patients exhibit an ...

insight.jci.org/articles/view/87310

Jun 16, 2016 ... *P < 0.05 by Mann-Whitney test vs. unstimulated B cells (Unstim) (G–I). ..... Tipton et al. described in SLE patients a population of activated naive B cells .... with human CD40LG (hCD40L-CHO cells) at Bristol-Myers Squibb. .... D. Stetsko, F. Casano, S. Kansal, P.M. Davis, J. Carman, C.K. Zhang, S.G. Nadler, ....